Chapman, M. S., J. Cirulli, and S. McBride. “Sustained Improvement in Patient-Reported Outcomes With Continued Apremilast Treatment over 104 Weeks in Patients With Moderate to Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S23, doi:10.25251/skin.2.supp.23.